News
MRK-WI
73.00
0.00%
0.00
MERCK & CO INC <MRK.N>: CITIGROUP RAISES TARGET PRICE TO $110 FROM $95
Reuters · 16h ago
BUZZ-US cuts child vaccine guidance; Merck's sales may drop by $2 billion, says Bernstein
Reuters · 1d ago
UPDATE 3-US cuts broad recommendation for four childhood vaccines including flu
Reuters · 1d ago
Merck Executives to Participate in J.P. Morgan Healthcare Conference
Reuters · 1d ago
BRIEF-FDA Grants Two National Priority Vouchers To Enlicitide Decanoate, Sacituzumab Tirumotecan
Reuters · 12/19/2025 20:53
SHARES OF SOME U.S. DRUGMAKERS RISE AFTER SIGNING DRUG PRICING DEAL WITH PRESIDENT TRUMP
Reuters · 12/19/2025 20:27
SHARES OF BRISTOL MYERS SQUIBB UP 1.8%, GILEAD SCIENCES UP 2.9%, AMGEN AND MERCK UP NEARLY 1%
Reuters · 12/19/2025 20:27
TRUMP: INSURANCE COMPANIES HAVE TO MAKE LESS MONEY
Reuters · 12/19/2025 20:02
TRUMP: INSURANCE COMPANY MEETING TO GET THEIR PRICES DOWN
Reuters · 12/19/2025 20:01
TRUMP: JOHNSON AND JOHNSON AND FOUR OTHER COMPANIES WILL BE COMING IN NEXT WEEK, THEY'VE AGREED TO LOWEST PRICE IN WORLD
Reuters · 12/19/2025 19:59
BRISTOL MYERS SQUIBB SAYS ITS DONATION TO STRATEGIC RESERVE WILL INCLUDE TOP SELLING BLOOD THINNER ELIQUIS
Reuters · 12/19/2025 19:54
Merck Announces $70 Billion Investment to Expand U.S. Manufacturing and R&D
Reuters · 12/19/2025 19:39
MERCK & CO INC: JANUVIA, JANUMET AND JANUMET XR WILL BE AVAILABLE TO ELIGIBLE AMERICAN PATIENTS AT A CASH PRICE, ABOUT 70% OFF OF CURRENT LIST PRICE
Reuters · 12/19/2025 19:39
TRUMP: ALL PHARMA COMPANIES HAVE AGREED
Reuters · 12/19/2025 19:28
TRUMP: UK NHS WILL PAY FAIR SHARE AND WE EXPECT OTHER EUROPEAN COUNTRIES TO DO SO, IF NOT WILL IMPOSE TARIFFS
Reuters · 12/19/2025 19:28
TRUMP: THE 3 OF THE 17 PHARMACEUTICAL COMPANIES WHO HAVE NOT AGREED ARE COMING IN NEXT WEEK
Reuters · 12/19/2025 19:28
AT LEAST SEVEN DRUG COMPANIES ARE SET TO ANNOUNCE PRICE CUTS WITH TRUMP AT WHITE HOUSE ON FRIDAY, INCLUDING GLAXOSMITHKLINE, MERCK AND SANOFI - WAPO
Reuters · 12/19/2025 17:35
BUZZ-U.S. STOCKS ON THE MOVE-Intuitive Machines, Palo Alto Networks, Redwire
Reuters · 12/19/2025 14:09
BUZZ-Evaxion down after Merck opts out of gonorrhea vaccine licensing agreement
Reuters · 12/19/2025 13:13
EVAXION A/S - ELIGIBLE FOR UP TO $592 MLN IN MILESTONE PAYMENTS ASSOCIATED WITH THE DEVELOPMENT OF EVX-B3
Reuters · 12/19/2025 12:00
More
Webull provides a variety of real-time MRK-WI stock news. You can receive the latest news about MERCK & CO through multiple platforms. This information may help you make smarter investment decisions.
About MRK-WI
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.